Multimodal Magnetic Resonance Imaging Evaluation of Primary Brain Tumors

被引:11
作者
Treister, Daniel [1 ]
Kingston, Sara [1 ]
Hoque, Kristina E. [1 ]
Law, Meng [1 ]
Shiroishi, Mark S. [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Radiol, Div Neuroradiol, Los Angeles, CA 90033 USA
关键词
CEREBRAL BLOOD-VOLUME; CONTRAST-ENHANCED MR; HIGH-GRADE GLIOMAS; DYNAMIC SUSCEPTIBILITY CONTRAST; APPARENT DIFFUSION-COEFFICIENT; GLIOBLASTOMA-MULTIFORME; PERFUSION MRI; MICROVASCULAR PERMEABILITY; SOLITARY METASTASES; MALIGNANT GLIOMAS;
D O I
10.1053/j.seminoncol.2014.06.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gliomas comprise 80% of primary brain neoplasms, with glioblastoma multiforme being the most commonly diagnosed glioma. The annual incidence is 5.26 per 100,000, or 17,000 newly diagnosed cases per year in the United States. The incidence increases with age, peaking between the 6th and 8th decades. Gliomas are more common among Caucasians and occur more often in men. They can be associated with certain rare hereditary syndromes including Cowden, Turcot, Li-Fraumeni, neurofibromatosis type 1 and type 2, tuberous sclerosis, and familial schwannomatosis. Known risk factors include a history of ionizing radiation, family history of glioma, and certain genetic susceptibility variants that are weakly associated with glioma. Preventative measures have not been shown to decrease the risk of later development. In addition, screening tests are unwarranted since early diagnosis and treatment have not been shown to improve outcome. (C) 2014 Published by Elsevier Inc.
引用
收藏
页码:478 / 495
页数:18
相关论文
共 163 条
  • [131] A "Vascular Normalization Index" as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
    Sorensen, A. Gregory
    Batchelor, Tracy T.
    Zhang, Wei-Ting
    Chen, Poe-Jou
    Yeo, Priscilla
    Wang, Meiyun
    Jennings, Dominique
    Wen, Patrick Y.
    Lahdenranta, Johanna
    Ancukiewicz, Marek
    di Tomaso, Emmanuelle
    Duda, Dan G.
    Jain, Rakesh K.
    [J]. CANCER RESEARCH, 2009, 69 (13) : 5296 - 5300
  • [132] Correlation between Cerebral Blood Volume Measurements by Perfusion-Weighted Magnetic Resonance Imaging and Two Year Progression-Free Survival in Gliomas
    Spampinato, M. V.
    Schiarelli, C.
    Cianfoni, A.
    Giglio, P.
    Welsh, C. T.
    Bisdas, S.
    Rumboldt, Z.
    [J]. NEURORADIOLOGY JOURNAL, 2013, 26 (04) : 385 - 395
  • [133] Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO
  • [134] 2-2
  • [135] Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions
    Sundgren, Pia C.
    Fan, Xiaoying
    Weybright, Patrick
    Welsh, Robert C.
    Carlos, Ruth C.
    Petrou, Myria
    McKeever, Paul E.
    Chenevert, Thomas L.
    [J]. MAGNETIC RESONANCE IMAGING, 2006, 24 (09) : 1131 - 1142
  • [136] Clinical value of proton magnetic resonance spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis
    Taylor, JS
    Langston, JW
    Reddick, WE
    Kingsley, PB
    Ogg, RJ
    Pui, MH
    Kun, LE
    Jenkins, JJ
    Chen, G
    Ochs, JJ
    Sanford, RA
    Heideman, RL
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05): : 1251 - 1261
  • [137] Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study
    Tedeschi, G
    Lundbom, N
    Raman, R
    Bonavita, S
    Duyn, JH
    Alger, JR
    DiChiro, G
    [J]. JOURNAL OF NEUROSURGERY, 1997, 87 (04) : 516 - 524
  • [138] Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV
  • [139] Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO
  • [140] 2-S